Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Morandi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|December 29, 2004
Angiopoietin-1 and myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|September 21, 2004
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironmentNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Current Pharmaceutical Biotechnology|December 16, 2006
Targeting pathways mediating bone diseaseNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Haematologica|February 16, 2005
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cellsNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Blood|January 13, 2006
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patientsNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Journal of Cardiovascular Electrophysiology|February 15, 2002
Role of implantable cardioverter defibrillators in dilated cardiomyopathyRiccardo Cappato, Silvia Negroni, Stefano Bentivegna, et al.
Cancer Research|August 19, 2007
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironmentNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|December 29, 2004
Angiopoietin-1 and myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|September 21, 2004
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironmentNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Current Pharmaceutical Biotechnology|December 16, 2006
Targeting pathways mediating bone diseaseNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Haematologica|February 16, 2005
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cellsNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Blood|January 13, 2006
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patientsNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Journal of Cardiovascular Electrophysiology|February 15, 2002
Role of implantable cardioverter defibrillators in dilated cardiomyopathyRiccardo Cappato, Silvia Negroni, Stefano Bentivegna, et al.
Cancer Research|August 19, 2007
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironmentNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Pageof 2